Breaking News

Where we stand in the pandemic as fall approaches; Illumina wins case against FTC in bid to hold onto Grail

  

 

Daily Recap

A third Covid autumn is upon us. Here's a look at where we stand

By J. Emory Parker and Andrew Joseph

Spencer Platt/Getty Images

There has been a steady stream of lives lost and a stealthy increase in children hospitalized for Covid this summer.

Read More

STAT+: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail

By Jonathan Wosen

Adobe

Illumina won its case against the FTC in its bid to hold onto Grail, a Bay Area early cancer detection company.

Read More

STAT+: Calm's head of science departs amid a shakeup at meditation app maker

By Mario Aguilar

Adobe

Calm's head of science, who helped build an impressive evidence base for the wellness app, has left the company.

Read More

A Q&A with WHO's Maria Van Kerkhove on Covid — and fatigue over the pandemic

By Helen Branswell

Richard Juilliart/Getty

The WHO's Maria Van Kerkhove knows you're over Covid-19, but that doesn't mean the effort to beat back the disease is over.

Read More

Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen

By Damian Garde and Allison DeAngelis and Adam Feuerstein

This week, we discuss the remarkable career of Stelios Papadopoulos, the Godfather of biotech who faces the daunting task of saving Biogen.

Read More

Opinion: 'Food is medicine' interventions should be the main course at White House nutrition conference

By Dariush Mozaffarian and David B. Waters

BRENDAN SMIALOWSKI/ via Getty

Medically tailored meals, produce prescriptions, and other food is medicine strategies can help address food and nutrition insecurity.

Read More

Opinion: Public health needs to be transformed. Health IT can help

By Leigh Burchell

JACK GUEZ/ Getty

A consistent, standards-based health IT approach to reporting, data management, and information exchange will improve U.S. public health.

Read More

Thursday, September 1, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments